Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 128.00%2.41B | ---- | -50.42%1.06B | ---- | 25.41%2.13B | ---- | 29.28%1.7B | ---- | -35.92%1.32B |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 26.53%-36M | ---- | -32.43%-49M | ---- | -23.33%-37M | ---- | -76.47%-30M | ---- | -21.43%-17M |
| Attributable subsidiary (profit) loss | ---- | -128.95%-11M | ---- | 1,050.00%38M | ---- | 88.24%-4M | ---- | -112.50%-34M | ---- | -6.67%-16M |
| Impairment and provisions: | ---- | -58.41%47M | ---- | 32.94%113M | ---- | 51.79%85M | ---- | -64.33%56M | ---- | 89.16%157M |
| -Impairment of property, plant and equipment (reversal) | ---- | -50.00%4M | ---- | 700.00%8M | ---- | -75.00%1M | ---- | -84.00%4M | ---- | 38.89%25M |
| -Impairmen of inventory (reversal) | ---- | -60.40%40M | ---- | 62.90%101M | ---- | 1.64%62M | ---- | -46.96%61M | ---- | 116.98%115M |
| -Impairment of trade receivables (reversal) | ---- | -50.00%2M | ---- | 300.00%4M | ---- | 80.00%-2M | ---- | -176.92%-10M | ---- | 1,400.00%13M |
| -Other impairments and provisions | ---- | --1M | ---- | ---- | ---- | 2,300.00%24M | ---- | -75.00%1M | ---- | -69.23%4M |
| Revaluation surplus: | ---- | -111.73%-21M | ---- | -16.74%179M | ---- | 50.35%215M | ---- | -20.56%143M | ---- | 9,100.00%180M |
| -Other fair value changes | ---- | -111.73%-21M | ---- | -16.74%179M | ---- | 50.35%215M | ---- | -20.56%143M | ---- | 9,100.00%180M |
| Asset sale loss (gain): | ---- | 78.31%-18M | ---- | 82.38%-83M | ---- | -11,875.00%-471M | ---- | -42.86%4M | ---- | 143.75%7M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---454M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 59.76%-33M | ---- | -382.35%-82M | ---- | -525.00%-17M | ---- | -42.86%4M | ---- | 800.00%7M |
| -Loss (gain) from selling other assets | ---- | 1,600.00%15M | ---- | ---1M | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -7.19%723M | ---- | -2.87%779M | ---- | 18.11%802M | ---- | 5.43%679M | ---- | 10.84%644M |
| -Amortization of intangible assets | ---- | -9.09%10M | ---- | 22.22%11M | ---- | 0.00%9M | ---- | 12.50%9M | ---- | -11.11%8M |
| -Other depreciation and amortization | ---- | ---- | ---- | ---- | ---- | 0.00%2M | ---- | 0.00%2M | ---- | --2M |
| Financial expense | ---- | -13.02%147M | ---- | 0.00%169M | ---- | 21.58%169M | ---- | 2.96%139M | ---- | -6.25%135M |
| Special items | ---- | -86.67%-28M | ---- | -157.69%-15M | ---- | 236.84%26M | ---- | -171.43%-19M | ---- | 84.09%-7M |
| Operating profit before the change of operating capital | ---- | 46.85%3.21B | ---- | -24.99%2.19B | ---- | 10.58%2.92B | ---- | 10.01%2.64B | ---- | -13.40%2.4B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 224.68%197M | ---- | 65.04%-158M | ---- | -1,908.00%-452M | ---- | -88.84%25M | ---- | 123.80%224M |
| Developing property (increase)decrease | ---- | -15.79%32M | ---- | 80.95%38M | ---- | 223.53%21M | ---- | 10.53%-17M | ---- | 73.61%-19M |
| Accounts receivable (increase)decrease | ---- | -142.37%-125M | ---- | 310.71%295M | ---- | 17.65%-140M | ---- | -225.00%-170M | ---- | 4,633.33%136M |
| Accounts payable increase (decrease) | ---- | 31.13%-261M | ---- | -281.34%-379M | ---- | 18.08%209M | ---- | -34.93%177M | ---- | 3.42%272M |
| Special items for working capital changes | ---- | -329.79%-108M | ---- | 115.51%47M | ---- | 25.55%-303M | ---- | -283.96%-407M | ---- | 40.11%-106M |
| Cash from business operations | ---- | 45.15%2.95B | ---- | -9.81%2.03B | ---- | 0.27%2.25B | ---- | -22.69%2.25B | ---- | 57.97%2.91B |
| Other taxs | ---- | -3.62%-429M | ---- | 7.80%-414M | ---- | -55.90%-449M | ---- | 31.10%-288M | ---- | -79.40%-418M |
| Interest paid - operating | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 9.09%-130M |
| Special items of business | 11.32%767M | ---- | 34,350.00%689M | ---- | -94.12%2M | ---- | -90.00%34M | ---- | -72.11%340M | ---- |
| Net cash from operations | 11.32%767M | 55.78%2.52B | 34,350.00%689M | -10.32%1.62B | -94.12%2M | -7.92%1.8B | -90.00%34M | -16.93%1.96B | -72.11%340M | 61.11%2.36B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 137.50%38M | -20.00%36M | -40.74%16M | 28.57%45M | 80.00%27M | 59.09%35M | 66.67%15M | 120.00%22M | 200.00%9M | 66.67%10M |
| Dividend received - investment | -75.00%1M | -42.86%8M | -20.00%4M | 133.33%14M | 66.67%5M | -25.00%6M | 0.00%3M | 300.00%8M | --3M | --2M |
| Loan receivable (increase) decrease | ---- | 400.00%10M | ---- | --2M | ---- | ---- | ---- | -33.33%12M | ---- | --18M |
| Decrease in deposits (increase) | -20,100.00%-800M | --25M | -71.43%4M | --0 | 182.35%14M | -376.92%-36M | -213.33%-17M | 200.00%13M | 400.00%15M | -218.18%-13M |
| Sale of fixed assets | 833.33%28M | -52.23%107M | -98.58%3M | 540.00%224M | 10,500.00%212M | 191.67%35M | -71.43%2M | 0.00%12M | 600.00%7M | -89.38%12M |
| Purchase of fixed assets | 16.91%-290M | 11.63%-707M | 20.14%-349M | 15.61%-800M | -1.16%-437M | -2.82%-948M | -35.42%-432M | -67.33%-922M | -41.15%-319M | 18.97%-551M |
| Selling intangible assets | ---- | ---- | ---- | ---- | --9M | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | -166.67%-8M | ---- | 82.35%-3M | 58.62%-12M | -183.33%-17M | -163.64%-29M | -100.00%-6M | 47.62%-11M | 75.00%-3M | 8.70%-21M |
| Sale of subsidiaries | ---- | 12.50%-7M | ---- | -300.00%-8M | ---- | --4M | ---- | ---- | ---- | -65.79%13M |
| Acquisition of subsidiaries | ---- | -184.38%-91M | -134.29%-82M | -255.56%-32M | -240.00%-35M | 86.15%-9M | 147.17%25M | 27.78%-65M | ---53M | 36.62%-90M |
| Recovery of cash from investments | 5.49%999M | -34.66%1.86B | -29.01%947M | 142.33%2.85B | 89.22%1.33B | -44.41%1.17B | -34.66%705M | 24.60%2.11B | 91.99%1.08B | 109.26%1.7B |
| Cash on investment | 19.98%-801M | 37.62%-1.85B | 32.41%-1B | -149.75%-2.97B | -224.07%-1.48B | 25.20%-1.19B | 38.08%-457M | 22.47%-1.59B | -49.09%-738M | -115.32%-2.05B |
| Other items in the investment business | 100.00%4M | -93.55%2M | -66.67%2M | -94.90%31M | 200.00%6M | 60,700.00%608M | 0.00%2M | -92.86%1M | -84.62%2M | -41.67%14M |
| Net cash from investment operations | -80.61%-829M | 7.69%-612M | -26.45%-459M | -89.43%-663M | -126.88%-363M | 14.43%-350M | -8,100.00%-160M | 57.53%-409M | 101.46%2M | -20.98%-963M |
| Net cash before financing | -126.96%-62M | 99.90%1.91B | 163.71%230M | -34.34%954M | -186.51%-361M | -6.20%1.45B | -136.84%-126M | 11.12%1.55B | -68.39%342M | 109.00%1.39B |
| Cash flow from financing activities | ||||||||||
| New borrowing | -6.49%2.51B | -66.13%3.91B | -56.04%2.68B | 209.71%11.55B | 231.18%6.1B | -28.54%3.73B | -5.69%1.84B | 59.19%5.22B | -6.65%1.95B | 33.46%3.28B |
| Refund | 24.67%-1.97B | 66.79%-3.88B | 56.36%-2.62B | -169.71%-11.69B | -212.23%-6B | -8.97%-4.34B | -10.33%-1.92B | -4.88%-3.98B | 15.85%-1.74B | -54.56%-3.79B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -99.80%2M | -57.14%3M | 3,174.19%1.02B |
| Interest paid - financing | 1.43%-69M | 16.56%-136M | 18.60%-70M | -7.95%-163M | -28.36%-86M | -11.03%-151M | 1.47%-67M | ---136M | ---68M | ---- |
| Dividends paid - financing | -115.18%-1.11B | -3.29%-784M | -219.25%-514M | -24.43%-759M | 23.70%-161M | 0.81%-610M | 24.10%-211M | 27.22%-615M | -95.77%-278M | -82.11%-845M |
| Absorb investment income | ---- | ---- | ---- | ---- | ---- | 0.00%1M | --1M | --1M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---2M | ---2M | ---- | ---- | ---1.93B | ---- | ---- |
| Other items of the financing business | 4,550.00%534M | 17.65%-14M | ---12M | 71.19%-17M | ---- | -555.56%-59M | ---- | -200.00%-9M | ---- | 94.00%-3M |
| Net cash from financing operations | 75.46%-147M | 16.26%-984M | -196.53%-599M | 23.80%-1.18B | 51.44%-202M | 1.72%-1.54B | -114.43%-416M | -227.56%-1.57B | -10.23%-194M | 19.22%-479M |
| Effect of rate | 47.06%-9M | -70.59%-29M | -21.43%-17M | 76.71%-17M | 69.57%-14M | -417.39%-73M | -1,633.33%-46M | -73.26%23M | 133.33%3M | 1,533.33%86M |
| Net Cash | 43.36%-209M | 517.65%923M | 34.46%-369M | -148.31%-221M | -3.87%-563M | -345.00%-89M | -466.22%-542M | -102.19%-20M | -83.66%148M | 1,136.49%915M |
| Begining period cash | 77.34%2.05B | -17.07%1.16B | -17.07%1.16B | -10.41%1.39B | -10.41%1.39B | 0.19%1.56B | 0.19%1.56B | 181.34%1.55B | 181.34%1.55B | 14.05%552M |
| Cash at the end | 137.92%1.83B | 77.34%2.05B | -5.75%770M | -17.07%1.16B | -15.60%817M | -10.41%1.39B | -43.19%968M | 0.19%1.56B | 17.60%1.7B | 181.34%1.55B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | 129.86%1.83B | 77.77%2.06B | --797M | -17.07%1.16B | ---- | --1.39B | ---- | ---- | ---- | ---- |
| Cash and cash equivalent balance | 129.86%1.83B | 77.77%2.06B | --797M | -17.07%1.16B | ---- | --1.39B | ---- | ---- | ---- | 181.34%1.55B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.